EC Fines Lundbeck, Generics Millions for Pay-for-Delay Settlement

The European Commission (EC) Wednesday slapped Lundbeck with a nearly $126 million fine, and levied fines totaling $70 million on four of its generic rivals, for their respective roles in 2002 pay-for-delay settlement deals tied to the Danish drugmaker’s antidepressant citalopram.
Drug Industry Daily